ARCHIVES

Early-Stage HER2+ Breast Cancer Patients Are At Significant Risk Of Recurrence

This article is from The Cancer Letter archive.

Vol. 31 No. 12 | December 26, 2008

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI Anniversary Party Moved To May 26; Patricia Randall Heads Women Radiologists

February 27, 1987

MDV3100 Improves Survival, Reduces Death Risk by 37%

November 25, 2011

Hematologic Malignancies: ASCO Meeting Highlights New Approaches To Treatment

July 30, 2004

Funding Opportunities: PAs Available.

January 28, 2005

Abraxane and Gemcitabine Improves Overall Survival

November 30, 2012

In Brief: Gallo, Montagnier, Four Others Share Japan Prize; RPMI, First Cancer Center, 90 Years Old

May 20, 1988